Chair(s): Olivier Sitbon, Mona Lichtblau, Judith Loffler-Ragg
Session type: State of the art session
Harm Jan Bogaard
Session content
Novel molecular insight into the development of CTEPH
Harm Jan Bogaard
Replay
Slides
Marion Delcroix
Replay
Slides
David Jenkins
Replay
Slides
Xavier Jais
Replay
Slides
Replay
Session aims
to place recent insights into the molecular pathogenesis of chronic thromboembolic pulmonary hypertension (CTEPH) into the context of the existing state of the art knowledge of CTEPH and its implementation in current clinical guidelines; to answer the question is whether and how these insights into pathophysiology will change future treatment of CTEPH and determine prognosis and outcomes for patients; to discuss novel targets for treatment and improvements in pharmacological therapy